Mastek Reports Q4FY26 Revenue Growth of 3.6%, Maintains Stable EBITDA at 16.1%
Mastek reported Q4FY26 revenue of INR938 crores, up 3.6% QoQ, with stable EBITDA margin of 16.1%. Full year FY26 revenue grew 7% to INR3,699 crores, while PAT increased 7.5% to INR404 crores. The 12-month order backlog reached $300.4 million, growing 13.5% YoY. AI-led deals comprised 9% of total business with 27 new AI programs added. The company generated INR542 crores operating cash and declared final dividend of INR16 per share. Margin guidance for FY27 remains at 16-16.1%.

*this image is generated using AI for illustrative purposes only.
Mastek delivered a stable performance in Q4FY26 with 3.6% quarter-on-quarter revenue growth, reaching INR938 crores, while maintaining operating EBITDA at 16.1%. The company reported dollar revenue of $103.5 million, up 1.4% sequentially. On a constant currency basis, revenue remained largely flat with marginal sequential growth of 0.3%. Despite salary increase impact of $1.1 million, the company sustained EBITDA margins through forex tailwind of 0.8% and execution of cost efficiencies.
Financial Performance Summary
| Performance Metric | Q4FY26 | FY26 Full Year |
|---|---|---|
| Revenue (INR) | INR938 crores | INR3,699 crores |
| Revenue Growth (QoQ) | 3.6% | 7% YoY |
| Revenue (USD) | $103.5 million | $421.2 million |
| Operating EBITDA | 16.1% | 15.8% |
| PAT | INR106 crores | INR404 crores |
| Order Backlog (12-month) | $300.4 million | 13.5% YoY growth |
The company closed FY26 with a 12-month backlog of $300.4 million, representing sequential growth of 1.5% and year-on-year growth of 13.5% in USD terms and 24.4% in INR terms. PAT for the quarter stood at INR106 crores, with a marginal sequential decline of 0.7% due to Labor Code true-up impact.
Order Book and Business Drivers
The order backlog demonstrated robust growth, increasing by 7.2% in INR terms and 1.6% in USD terms sequentially. AI-led deals continue to gain traction, comprising 9% of total deals. The company added more than 27 net new AI-focused customer programs during the quarter, spanning both AI for technology and AI for business-related initiatives.
Geographic performance showed resilience, with U.K. and AMEA regions growing sequentially in Q4, while the U.S. remained largely flat due to project right-shifting. The U.K. business maintained healthy EBITDA of nearly 20%. Healthcare and Life Sciences continues to show positive demand outlook, while Financial Services emerged as a strong performer during the quarter.
Operational Parameters and Cash Position
During the year, the company generated INR542 crores of operating cash, up 35% year-on-year. Cash and cash equivalents as of March 31, 2026, stood at INR938 crores, representing a 51% increase compared to March 2025. The company achieved its lowest Days Sales Outstanding (DSO) in the last 12 quarters at 73 days, supported by strong collections of $125 million during Q4.
Reflecting confidence in the business, Mastek declared a final dividend of INR16 per share, in addition to the interim dividend of INR8 per share declared during Q3. Total headcount stood at 4,730 with an addition of 54 employees during the quarter. Utilization rate improved to 80% in Q4, an increase of 3.3% from Q3.
Guidance and Outlook
Mastek has maintained its margin guidance of 16-16.1% for FY27, balancing operational efficiency improvements against pricing competitiveness and client budget reduction requests. The company expects FY27 to deliver better performance than the previous year, supported by strong order book momentum and positive demand indicators across key verticals including Healthcare, BFSI, and Retail.
The management emphasized that FY26 was a year of fundamental resets across geographies, particularly in North America where the team and focus have been restructured. As the company enters FY27, it anticipates positive growth driven by the execution of the 12-month order backlog and continued momentum in AI-led business transformation services.
Financial Guidance
| Financial Guidance | Target Range |
|---|---|
| Margin Guidance | 16-16.1% |
| FY27 Growth Outlook | Better than FY26 |
Historical Stock Returns for Mastek
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -2.63% | +0.14% | +22.96% | -21.59% | -23.28% | +23.72% |
How will Mastek's AI integration strategy impact its competitive positioning against larger IT services providers in the next 12-18 months?
What specific measures is the new North American leadership implementing to accelerate growth beyond the current two-quarter order book momentum?
Could the timing-related challenges in Healthcare and Life Sciences vertical signal broader industry headwinds that might affect future quarters?


































